Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...

Sanofi, drugmaker behind Zantac, has agreed to settle 4,000 lawsuits The suits claim that discontinued Zantac contained cancer-causing chemicals READ MORE: Has heartburn pill that has been given ...

Operating profit at GSK fell by 86 per cent due to a charge related to the settlement of Zantac settlements the company said ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued heartburn drug Zantac caused cancer.

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.

"Strong growth in specialty medicines helped to offset lower vaccine sales and reflected successful new product launches ... or about 80,000, of the Zantac liability cases against the group ...

The new 102-page opinion contradicts a December 2022 federal court ruling which dismissed all cases alleging five cancer types. The complaints revolve around allegations that Zantac and other ...

(WJET/WFXP) — UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level Zantac cases. The lawsuits claimed that the now ...

On Wednesday, GSK plc (NYSE:GSK) reached agreements with ten plaintiff firms representing approximately 80,000 Zantac product liability cases in the U.S. state courts. These cases account for 93% ...

Additionally, GSK has reached an agreement in principle to pay a total of $70 million to settle a Zantac qui tam complaint ... 1990s by Andrew Mariathasan in New York, with the goal of covering ...

Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...